Showing results (71-80 of 86) with videos related to
Sort By:
Pageof 9
Biochemical Pharmacology|August 11, 2023
Discovery of novel carboxylesterase 2 inhibitors for the treatment of delayed diarrhea and ulcerative colitisZhijun Cao, Yuxia Liu, Siliang Chen, et al.Bioorganic Chemistry|June 10, 2023
Design, synthesis, and biological evaluation studies of novel carboxylesterase 2 inhibitors for the treatment of irinotecan-induced delayed diarrheaZhongcheng Yang, Zhijun Cao, Wenxin Wang, et al.Clinical Epigenetics|October 7, 2023
Effects of iron homeostasis on epigenetic age acceleration: a two-sample Mendelian randomization studyZhihao Wang, Yi Liu, Shuxin Zhang, et al.Frontiers in Public Health|February 20, 2026
The relationship between medical students' attitudes toward artificial intelligence and their personality traits: a multicenter study in ChinaJinxin Qi, Yuxiao Zeng, Hao Wang, et al.Scientific Reports|January 3, 2025
Weakly supervised deep learning-based classification for histopathology of gliomas: a single center experienceMingrong Zuo, Xiang Xing, Linmao Zheng, et al.Journal of Medicinal Chemistry|January 24, 2025
Discovery of First-in-Class FXR and HSD17B13 Dual Modulator for the Treatment of Metabolic Dysfunction-Associated Fatty Liver DiseaseShixuan Jiao, Qiang Ren, Lianru Chen, et al.International Journal of Surgery (London, England)|February 4, 2025
Glioma-induced neural functional remodeling in the hand motor cortex: precise mapping with ECoG grids during awake craniotomyTao Chang, Yihan Wu, Yuxin Quan, et al.Frontiers in Oncology|July 29, 2026
Case Report: Preoperative embolization for a large intracranial pheochromocytoma metastasis: a novel approach to minimize intraoperative riskLloyd Mulenga Mwibwe, Qing Mao, Tao Chang, et al.Cell Death and Differentiation|December 13, 2025
Chemotherapy induces multiple sclerosis-like neuropathologies that can be rescued by clobetasolQiuyun Yuan, Wanchun Yang, Siliang Chen, et al.Journal of Medicinal Chemistry|April 20, 2023
Discovery of the First-in-Class Intestinal Restricted FXR and FABP1 Dual Modulator ZLY28 for the Treatment of Nonalcoholic Fatty Liver DiseaseQiang Ren, Ya Chen, Zongtao Zhou, et al.Pageof 9